Pharmacists in Aston, Pennsylvania


14 Pharmacists found in Aston
male pharmacist

Mr. Allen Gordon Irons Jr., R.PH.


Pharmacist
40 Dogwood Ln, Aston, PA 19014
610-358-2563    

female pharmacist

Miss Amy Rose Lamorgia, PHARMD


Pharmacist
3620 Concord Rd, Aston, PA 19014
610-485-8102    

female pharmacist

Divya G Hattay


Pharmacist
3620 Concord Rd, Aston, PA 19014
610-485-8102    



male pharmacist

Dr. Jonathan Calvert Feathers, PHARMD



10 Scheivert Ave, Aston, PA 19014
610-494-1445    

male pharmacist

Mr. Joseph Francis Mcneill Jr., RPH



10 Scheivert Ave, Aston, PA 19014
610-494-1445    

female pharmacist

Kimberly Wong, RPH


Pharmacist
5020 Pennell Rd, Aston, PA 19014
610-497-2225    

female pharmacist

Mrs. Me Lee Ghassemi, R.PH.


Pharmacist
3620 Concord Road, Walgreens Pharmacy, Aston, PA 19014
610-485-8102     610-485-8978

female pharmacist

Mi Kyong Kim


Pharmacist
3620 Concord Rd, Aston, PA 19014
610-485-8102    

male pharmacist

Michael John Filipkowski, RPH


Pharmacist
4400 Pennell Rd, Aston, PA 19014
610-494-2055    

male pharmacist

Mohsen Ghorbanalizadeh, PHARMD


Pharmacist
4400 Pennell Rd, Aston, PA 19014
610-494-2055     610-485-3029

female pharmacist

Paulina Westfahl, PHARMD


Pharmacist
3400 Concord Rd, Aston, PA 19014
610-497-5890    

female pharmacist

Regina Fallon, PHARMD


Pharmacist
3620 Concord Rd, Aston, PA 19014
610-485-8102    

male pharmacist

Mr. Robert Marvin Bell, R.PH.


Pharmacist
10 Scheivert Ave, Aston, PA 19014
610-494-1445    

female pharmacist

Dr. Zainab Gernerd


Pharmacist
4400 Pennell Rd, Aston, PA 19014
610-494-2055     610-485-3029


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.